CONMED Corporation

DB:EC8 Stock Report

Market Cap: €2.1b

CONMED Future Growth

Future criteria checks 2/6

CONMED is forecast to grow earnings and revenue by 13.8% and 6.7% per annum respectively. EPS is expected to grow by 14.4% per annum. Return on equity is forecast to be 14.9% in 3 years.

Key information

13.8%

Earnings growth rate

14.4%

EPS growth rate

Medical Equipment earnings growth14.2%
Revenue growth rate6.7%
Future return on equity14.9%
Analyst coverage

Good

Last updated31 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:EC8 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,4991691901867
12/31/20251,3991391791588
12/31/20241,3021181371298
9/30/20241,288132166180N/A
6/30/20241,27699159175N/A
3/31/20241,26282142158N/A
12/31/20231,24564106125N/A
9/30/20231,169583857N/A
6/30/20231,139881637N/A
3/31/20231,099-94729N/A
12/31/20221,045-811233N/A
9/30/20221,069-835979N/A
6/30/20221,042-1145674N/A
3/31/20221,020687490N/A
12/31/20211,0116397112N/A
9/30/2021989628398N/A
6/30/20219795499112N/A
3/31/2021881137083N/A
12/31/2020862105265N/A
9/30/202087406985N/A
6/30/202087006987N/A
3/31/20209513484103N/A
12/31/2019955297595N/A
9/30/2019933296079N/A
6/30/2019901282847N/A
3/31/2019876312946N/A
12/31/2018860415875N/A
9/30/2018840725571N/A
6/30/201882873N/A80N/A
3/31/201881271N/A75N/A
12/31/201779655N/A66N/A
9/30/201777815N/A58N/A
6/30/201777316N/A70N/A
3/31/201776912N/A72N/A
12/31/201676415N/A40N/A
9/30/201675016N/A36N/A
6/30/201673517N/A24N/A
3/31/201672222N/A17N/A
12/31/201571930N/A51N/A
9/30/201572334N/A64N/A
6/30/201572927N/A65N/A
3/31/201573630N/A63N/A
12/31/201474032N/A65N/A
9/30/201474731N/A67N/A
6/30/201475035N/A83N/A
3/31/201475334N/A93N/A
12/31/201376336N/A81N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: EC8's forecast earnings growth (13.8% per year) is above the savings rate (1%).

Earnings vs Market: EC8's earnings (13.8% per year) are forecast to grow slower than the German market (20.9% per year).

High Growth Earnings: EC8's earnings are forecast to grow, but not significantly.

Revenue vs Market: EC8's revenue (6.7% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: EC8's revenue (6.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: EC8's Return on Equity is forecast to be low in 3 years time (14.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y